CVE-2018-12653

CVE-2018-12653 is a medium-severity vulnerability in Myadrenalin Adrenalin with a CVSS 3.x base score of 6.1. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-79.

Key facts

Description

A Reflected Cross Site Scripting (XSS) vulnerability exists in Adrenalin HRMS 5.4.0. An attacker can input malicious JavaScript code in /RPT/SSRSDynamicEditReports.aspx via 'ReportId' parameter.

Frequently asked questions

What is CVE-2018-12653?
A Reflected Cross Site Scripting (XSS) vulnerability exists in Adrenalin HRMS 5.4.0. An attacker can input malicious JavaScript code in /RPT/SSRSDynamicEditReports.aspx via 'ReportId' parameter.
How severe is CVE-2018-12653?
CVE-2018-12653 has a CVSS 3.x base score of 6.1, rated medium severity. It is exploitable over network with low attack complexity, requires no privileges and user interaction. Impact on confidentiality is low, integrity low, and availability none.
Is CVE-2018-12653 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 3% (84th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2018-12653?
CVE-2018-12653 affects Myadrenalin Adrenalin. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2018-12653?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2018-12653 published?
CVE-2018-12653 was published on 2019-03-25 and last updated on 2026-06-17.

References

Affected products (1)

More vulnerabilities in Myadrenalin Adrenalin

All CVEs affecting Myadrenalin Adrenalin →

Other CWE-79 (Cross-site Scripting (XSS)) vulnerabilities

Browse all CWE-79 (Cross-site Scripting (XSS)) vulnerabilities →